For patients with type 2 diabetes (T2D) and chronic obstructive pulmonary disorder (COPD), sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs ...

Though more research is needed to understand who might benefit from GLP-1 agonists for addiction, early studies suggest that the approach holds promise.

Treatment for OUD is currently dominated by opioid agonist therapies that are highly regulated due to their liability for ...

The truth is that muscle growth can vary widely from one person to another. Here's how to maximize yours. Ever wonder why ...

Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...

If you find yourself jolting awake in the early morning hours, it may not necessarily be due to unexplained insomnia. Instead ...

Dr. Corey L. Hartman tells ESSENCE how this prescription can have long-term effects not just the body—but also on our skin.

Research shows bimagrumab may prevent muscle and bone loss associated with weight loss medications like Wegovy, offering hope ...

Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...

When celebrities reveal their experiences with newer weight-loss drugs, there are upsides and downsides for patients and ...

RAs, originally for diabetes, may impact brain health, finding potential benefits for dementia and addiction but inconsistent results for mood disorders.